Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy

Practical guidance for the management of aromatase inhibitor-associated bone loss

(2008) P. Hadji et al.   ANNALS OF ONCOLOGY

Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane

(2008) A Stigliano et al.   ENDOCRINE-RELATED CANCER

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

(2008) Richard Eastell et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

(2008)   LANCET ONCOLOGY

Aromatase Inhibitors: Are There Differences Between Steroidal and Nonsteroidal Aromatase Inhibitors and Do They Matter?

(2008) W. R. Miller et al.   ONCOLOGIST

Aromatase inhibitor-induced arthralgia: Clinical experience and treatment recommendations

(2007) R.E. Coleman et al.   CANCER TREATMENT REVIEWS